What’s New in Musculoskeletal Tumor Surgery 2025
Key topics in musculoskeletal tumor surgery are covered in the new JBJS Specialty Update What’s New in Musculoskeletal Tumor Surgery…
Treatment Benefit? Two Double-Blinded RCTs Examine the Evidence
Dr. Matt Schmitz, JBJS Deputy Editor for Social Media, offers this post on 2 level-I studies in the current issue …
What’s New in Musculoskeletal Tumor Surgery 2024
Key topics in orthopaedic oncology are discussed in the new JBJS Guest Editorial What’s New in Musculoskeletal Tumor Surgery. …
New Study Evaluates Peroneal Nerve Decompression in Multiple Hereditary Exostoses
JBJS Deputy Editor for Social Media Dr. Matt Schmitz offers this post on a new study that evaluates peroneal nerve …
What’s New in Musculoskeletal Tumor Surgery 2023
Recent findings in orthopaedic oncology and musculoskeletal tumor management are highlighted in the new JBJS Guest Editorial What’s New in …
What’s New in Musculoskeletal Basic Science 2023
Recent findings related to bone loss and bone healing, among other important topics, are presented in the new JBJS Guest …
Now Available: JBJS Supplement on the Secondary Analyses from the PARITY Trial
An international team of musculoskeletal oncology experts have explored several important questions regarding the surgical treatment of patients through secondary …
What’s New in Musculoskeletal Tumor Surgery 2022
Recent studies on therapies for soft-tissue tumors, prophylactic antibiotic regimens, and other key topics are presented in the new JBJS …
Impending vs. Completed Pathological Long-Bone Fractures: What Are the Decision Points?
When patients present with identified bone metastases, a known primary diagnosis, and pain, the orthopaedic surgeon is nearly always contacted. …